[ET Net News Agency, 1 February 2024] REMEGEN (09995) rose 10% to HK$16.74.
It hits an intra-day high of HK$16.76, and an intra-day low of HK$15.06, hitting a
historical low. The total shares traded was 1.75 million, with a value of HK$27.88m. The
active buy/sell ratio is 55:45, with net buying turnover of HK$2.67m. MORGAN STANLEY HK
SEC accounts for greatest net responsive buying turnover of HK$1.99m, with volume weighted
average price of HK$15.86. CHINA INV INFO accounts for greatest net responsive selling
turnover of HK$2.46m, with volume weighted average price of HK$15.833.
Basic Information
=================
----------------------------------
Nominal 16.740 % Chg +9.99%
High 16.760 Low 15.060
Shares Tr 1.75m Turnover 27.88m
10-D SMA 19.525 %H.V 122.071
20-D SMA 25.528 VWAP 15.935
50-D SMA 33.731 RSI14 24.949
----------------------------------
Status: Hitting a historical low, active buy/sell ratio is 55:45, with net buying turnover
of HK$2.67m
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
REMEGEN (09995) 16.74 +9.99
HUTCHMED (00013) 20.70 +4.86
GENSCRIPT BIO (01548) 13.90 +7.25
INNOVENT BIO (01801) 33.00 +4.76
JXR (01951) 2.26 +4.15
EVEREST MED-B (01952) 16.54 +5.48
WUXI XDC (02268) 21.10 +6.03
WUXI BIO (02269) 21.70 +5.85
BEIGENE (06160) 89.95 -0.66
AKESO (09926) 41.60 +4.92
---------------------------------------------
(ed)